GPAM and cerebral palsy: The GPAM knockout cell line retained a normal karyotype and exhibited pluripotent stem cell markers and differentiation capabilities similar to wild-type hESCs, making it a valuable resource for modeling the disease in brain organoids and conducting drug screening for cerebral palsy [224].